InnovAge Holding Corp. 8-K

What Happened

• On March 17, 2026, InnovAge Holding Corp. (INNV) disclosed under Item 7.01 (Regulation FD Disclosure) that it will meet with investors and analysts at the KeyBank Capital Markets Healthcare Forum and expects to reaffirm its full-year fiscal 2026 guidance.
• The guidance to be reaffirmed was originally provided in the Company’s press release dated February 3, 2026, which accompanied InnovAge’s announcement of results for the second fiscal quarter ended December 31, 2026.
• The presentation the Company will use at these meetings has been posted and is publicly available on InnovAge’s Investor Relations site at https://investor.innovage.com.

Key Details

• Filing date: March 17, 2026 (Item 7.01, Regulation FD Disclosure).
• Event: KeyBank Capital Markets Healthcare Forum investor/analyst meetings.
• Reference: FY2026 guidance as disclosed in press release dated February 3, 2026 (related to Q2 results).
• Presentation: Posted on InnovAge’s investor website and accessible to the public.

Why It Matters

• A public reaffirmation of FY2026 guidance signals management is standing by the company’s previously reported outlook and quarterly results.
• The 8-K itself does not provide new financial figures or changes to guidance; it serves to comply with disclosure rules and direct investors to the posted presentation and the February 3 press release for the detailed numbers.
• Investors should review the Feb. 3, 2026 press release and the posted presentation for the specific earnings, revenue, and guidance figures referenced.